Dual-action approach targeting inflammation shows potential as Type 1 diabetes treatment
A new strategy may help prevent or slow the progression of Type 1 diabetes.
Noticias
Discovery of antibiotic resistance in newly identified bacterium
The recently discovered bacterium Staphylococcus borealis, named after the Northern Lights, turns out to be resistant to several classes of antibiotics. The elderly are especially at risk.
New molecular label could lead to simpler, faster tuberculosis tests
Chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world’s deadliest pathogen. This labeling could lead to simpler, faster TB tests.
Mapping immune cell battles to understand gene expression changes
Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease. With this new resource, called ImmGenMaps, researchers are building a map of all major organs—and tracking how all types of immu…
Suppressing key enzymes could improve lung cancer treatment outcomes
Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some patients with non-small cell lung cancer (NSCLC), the most common type of lung cancer, according to a new Yale study.
Immune system shifts may explain why some long COVID patients struggle to breathe
Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of COVID-19 survivors, particularly those struggling with persistent breathing issues. The study shows that these patients have distin…
Is it dangerous to kiss someone who’s eaten gluten if you have celiac disease?
Celiac disease is not a food allergy or intolerance. It’s an autoimmune disease that makes the body attack the small intestine if gluten (found in wheat, rye and barley) reaches the gut. Even a small amount—a tiny bread crumb—can cause damage and infla…
Antibody therapy explored to combat bird flu
While the risk of contracting and dying from the H5N1 avian flu remains low for humans, researchers continue to hunt for vaccines and treatments in case the virus mutates to spread more easily between animals and humans—or among humans themselves.
Scientists identify potential new target for neurodegenerative diseases
Monash University scientists have identified a potential new drug target to alleviate neuroinflammation, which is reported in many neurodegenerative diseases, such as Alzheimer’s, Parkinson’s and motor neuron disease.
New gene-editing therapy shows early success in fighting advanced GI cancers
Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show encouraging signs of safety and potential effectiveness of …